Xcout Intel
Synthace
Synthace provides software that helps life science researchers design, run, and analyze high-dimensional biological experiments. Headquartered in London at the WestWorks building, the company focuses on delivering AI-ready data.
Subscribe to see Synthace’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Synthace at a glance
Synthace is a life sciences company headquartered in United Kingdom, founded in 2011. It has raised at least $53.6M across the 3 funding rounds on record. Its most recent funding round, Series C, raised $25.6M in December 2025. Xcout tracks 6 named people at Synthace, including Guy Levy-Yurista (CEO).
Synthace leadership
- Guy Levy-YuristaCEO
- Michael SadowskiChief Technology Officer
- Richard FryChief Commercial Officer
- Markus GershaterChief Executive Officer & Co-Founder
- Abdul Rahim BahVP of Engineering
- Nuno LeitãoDirector of Science
Synthace funding rounds
At least $53.6M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $25.6M | 2 named | |
| Series B | $26M | 4 named | |
| Seed | $2M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Synthace competitors
A few of Synthace's closest competitors — see the full list of competitors and alternatives →
Ginkgo Bioworks is a biotechnology research company headquartered in Boston, Massachusetts, that provides autonomous lab platforms for automated biological experiments.
Danu Insights Ltd provides an AI-driven platform designed to optimize experiments for the life sciences sector, serving industries ranging from biotechnology to clinical research. The company's technology aims to help organizations improve experiment outcomes and accelerate research and development.
Foundational Bio builds AI-native, fully automated laboratories designed to replace manual research workflows and accelerate experimentation speeds. Headquartered in New York City, the company operates in the research services sector.
Adaptyv Biosystems operates an automated cloud laboratory that provides protein testing and validation services for protein designers and AI-first engineering teams. The company allows users to submit protein sequences digitally and delivers experimental data such as binding affinity, expression, and thermostability measurements.
ChainReactor Technologies provides infrastructure for industrial biology by combining physical AI, process engineering, and patented advanced manufacturing. The company offers modular benchtop bioreactors and a large biological model to help biomanufacturers predict cell behavior and test processes at scale before commercial production.
Petrichor Bio builds fabless wet labs designed specifically for frontier AI labs to address data constraints in biological research. The company provides specialized biological data and infrastructure to support advancements in AI-driven biology.
Get Synthace's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Synthace in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access